Fiorentino Ilaria, Gualtieri Roberto, Barbato Vincenza, Mollo Valentina, Braun Sabrina, Angrisani Alberto, Turano Mimmo, Furia Maria, Netti Paolo A, Guarnieri Daniela, Fusco Sabato, Talevi Riccardo
Dipartimento di Biologia, Università di Napoli "Federico II", Complesso Universitario di Monte S Angelo,Via Cinthia 80126 Napoli, Italy.
Italian Institute of Technology@CRIB Center for Advanced Biomaterials for Health Care, Largo Barsanti e Matteucci, 53, 80125 Napoli, Italy.
Exp Cell Res. 2015 Jan 15;330(2):240-247. doi: 10.1016/j.yexcr.2014.09.017. Epub 2014 Sep 22.
Nanoparticle (NPs) delivery systems in vivo promises to overcome many obstacles associated with the administration of drugs, vaccines, plasmid DNA and RNA materials, making the study of their cellular uptake a central issue in nanomedicine. The uptake of NPs may be influenced by the cell culture stage and the NPs physical-chemical properties. So far, controversial data on NPs uptake have been derived owing to the heterogeneity of NPs and the general use of immortalized cancer cell lines that often behave differently from each other and from primary mammalian cell cultures. Main aims of the present study were to investigate the uptake, endocytosis pathways, intracellular fate and release of well standardized model particles, i.e. fluorescent 44 nm polystyrene NPs (PS-NPs), on two primary mammalian cell cultures, i.e. bovine oviductal epithelial cells (BOEC) and human colon fibroblasts (HCF) by confocal microscopy and spectrofluorimetric analysis. Different drugs and conditions that inhibit specific internalization routes were used to understand the mechanisms that mediate PS-NP uptake. Our data showed that PS-NPs are rapidly internalized by both cell types 1) with similar saturation kinetics; 2) through ATP-independent processes, and 3) quickly released in the culture medium. Our results suggest that PS-NPs are able to rapidly cross the cell membrane through passive translocation during both uptake and release, and emphasize the need to carefully design NPs for drug delivery, to ensure their selective uptake and to optimize their retainment in the targeted cells.
纳米颗粒(NPs)体内递送系统有望克服与药物、疫苗、质粒DNA和RNA材料给药相关的许多障碍,这使得对其细胞摄取的研究成为纳米医学的核心问题。NPs的摄取可能受细胞培养阶段和NPs物理化学性质的影响。到目前为止,由于NPs的异质性以及永生化癌细胞系的普遍使用(这些细胞系彼此之间以及与原代哺乳动物细胞培养物的行为通常不同),关于NPs摄取的数据存在争议。本研究的主要目的是通过共聚焦显微镜和荧光光谱分析,研究标准化良好的模型颗粒,即荧光44纳米聚苯乙烯NPs(PS-NPs),在两种原代哺乳动物细胞培养物,即牛输卵管上皮细胞(BOEC)和人结肠成纤维细胞(HCF)中的摄取、内吞途径、细胞内命运和释放情况。使用不同的药物和抑制特定内化途径的条件来了解介导PS-NP摄取的机制。我们的数据表明,PS-NPs能被两种细胞类型快速内化:1)具有相似的饱和动力学;2)通过不依赖ATP的过程,以及3)快速释放到培养基中。我们的结果表明,PS-NPs在摄取和释放过程中都能够通过被动转运快速穿过细胞膜,并强调需要精心设计用于药物递送的NPs,以确保其选择性摄取并优化其在靶细胞中的保留。